PAR (PAR:ASX) Investor Relations Material

Overview

PAR Technology Corporation, a leading provider of innovative technology solutions to the restaurant and retail industries globally, is divided into two segments: Restaurant/Retail and Government. While the Restaurant/Retail segment is dedicated to generating customer loyalty and engagement solutions via its Punchh enterprise, it also boasts an omnichannel digital ordering solution, known as MENU. Additionally, this segment provides other robust solutions, including Brink POS, back-office cloud software and payment processing services, among others. The Government segment has been leading in providing mission systems operations and maintenance, commercial software products, and engineering support, among other services to the United States Department of Defense and other federal agencies. PAR Technology Corporation's offerings encompass intelligence, surveillance and reconnaissance solutions, information technology infrastructure library services, and satellite control center services, as well as licensed software products. With its headquarters in New Hartford, New York, the company was founded in 1968, and its extensive portfolio of hardware solutions includes point-of-sale hardware, wireless headsets for drive-thru order-taking, and peripherals. Furthermore, the Restaurant/Retail segment provides hardware repair services, installation and implementation, training, and on-site support services.

Frequently Asked Questions

What is PAR's ticker?

PAR's ticker is PAR

What exchange is PAR traded on?

The company's shares trade on the ASX stock exchange

Where are PAR's headquarters?

They are based in Melbourne, Australia

How many employees does PAR have?

There are 1-10 employees working at PAR

What is PAR's website?

It is partech.com

What type of sector is PAR?

PAR is in the Healthcare sector

What type of industry is PAR?

PAR is in the Biotechnology industry

Who are PAR's peers and competitors?

The following five companies are PAR's industry peers:

- Intellia Therapeutics

- Catalyst Biosciences, Inc.

- Mereo BioPharma Group plc

- Bicycle Therapeutics plc

- Oncternal Therapeutics, Inc.